Sponsor pipeline

TingBo Liang clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1

NCT ID	Title	Condition	Status	Updated
Phase 1
NCT06478251	T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment…	Tumor, Solid	Active, Not Recruiting	2026-10-15

Get alerts when TingBo Liang's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.